Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gorelov, Dmitry
NCT06284265: Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis	Recruiting	3	632	RoW	Raphamin, MMH-407, Placebo	Materia Medica Holding	Cystitis Chronic, Cystitis Bacterial, Recurrence of Chronic Bacterial Cystitis	12/26	12/26
NCT03638830: Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa	Recruiting	2	777	RoW	Ftortiazinon (tablets 300 mg) 1/2 dose +placebo+ Maxipim, Ftortiazinon (tablets 300 mg) full dose + Maxipim, placebo+Maxipim	Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Acellena Contract Drug Research and Development	Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa, Pseudomonas Aeruginosa, Pseudomonas Infections, Urinary Tract Infections	12/21	01/22
Grigoriev, Vladislav
NCT06284265: Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis	Recruiting	3	632	RoW	Raphamin, MMH-407, Placebo	Materia Medica Holding	Cystitis Chronic, Cystitis Bacterial, Recurrence of Chronic Bacterial Cystitis	12/26	12/26
Aboyan, Igor
NCT06284265: Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis	Recruiting	3	632	RoW	Raphamin, MMH-407, Placebo	Materia Medica Holding	Cystitis Chronic, Cystitis Bacterial, Recurrence of Chronic Bacterial Cystitis	12/26	12/26
NCT04209543 / 2019-001289-14: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)	Completed	3	1570	Europe, Canada, US, RoW	Estetrol, Placebo, Progesterone	Estetra, ICON Clinical Research	Vasomotor Symptoms, Menopausal Symptoms	02/24	02/24